CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 135 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $4,608,000 | -28.5% | 900,000 | 0.0% | 0.18% | -21.0% |
| Q2 2019 | $6,444,000 | -32.1% | 900,000 | +25.9% | 0.23% | -36.3% |
| Q1 2019 | $9,495,000 | +96.6% | 715,000 | +16.5% | 0.37% | +60.5% |
| Q4 2018 | $4,829,000 | -29.0% | 613,604 | 0.0% | 0.23% | -7.3% |
| Q3 2018 | $6,799,000 | -12.7% | 613,604 | +5.8% | 0.25% | -18.0% |
| Q2 2018 | $7,784,000 | +22.3% | 580,000 | +18.4% | 0.30% | +10.3% |
| Q1 2018 | $6,365,000 | +53.7% | 490,000 | +8.9% | 0.27% | +44.7% |
| Q4 2017 | $4,140,000 | +14.1% | 450,000 | 0.0% | 0.19% | +12.6% |
| Q3 2017 | $3,627,000 | +269.0% | 450,000 | +350.0% | 0.17% | +45.2% |
| Q4 2014 | $983,000 | -52.1% | 100,000 | -66.7% | 0.12% | -63.7% |
| Q3 2014 | $2,052,000 | – | 300,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $11,887,000 | 8.85% |
| Foresite Capital Management IV, LLC | 1,787,094 | $12,939,000 | 2.92% |
| Copernicus Capital Management, LLC | 278,416 | $2,016,000 | 1.92% |
| Sio Capital Management, LLC | 1,159,236 | $8,393,000 | 1.66% |
| ACUTA CAPITAL PARTNERS, LLC | 765,000 | $5,539,000 | 1.50% |
| Avoro Capital Advisors LLC | 10,300,000 | $74,572,000 | 1.06% |
| Boxer Capital, LLC | 4,000,000 | $28,960,000 | 1.00% |
| Vivo Capital, LLC | 2,089,356 | $15,127,000 | 0.87% |
| EAM Global Investors LLC | 284,534 | $2,060,000 | 0.76% |
| Versant Venture Management, LLC | 543,753 | $3,937,000 | 0.72% |